ProgModule: A novel computational framework to identify mutation driver modules for predicting cancer prognosis and...

Area of Science:

• Genomics
• Computational Biology
• Oncology

Background:

• Cancer development is driven by mutations in key genes, leading to uncontrolled cell growth.
• Existing methods for identifying cancer-causing mutations are computationally intensive and lack clinical utility.

Purpose of the Study:

• To develop an advanced computational framework, ProgModule, for identifying mutation driver modules.
• To enhance cancer prognosis and predict immunotherapy response using these identified modules.

Main Methods:

• Introduced the Prognosis-Related Mutually Exclusive Mutation (PRMEM) score to balance mutation coverage and combinations.
• Developed ProgModule, a computational framework for identifying mutation driver modules.

Main Results:

• ProgModule successfully identified driver modules in BLCA and HNSC cohorts, stratifying patients and serving as prognostic biomarkers.
• The framework demonstrated robust prognostic performance across various cancer types and model parameters.
• Identified driver modules predicted immunotherapy benefit more effectively than current signatures and suggested potential therapeutic targets.

Conclusions:

• ProgModule is a powerful tool for identifying mutation driver modules for cancer prognosis and immunotherapy response.
• Genes within these modules represent potential therapeutic targets, contributing to precision oncology advancements.